June 15, 2018 / 4:13 AM / 3 days ago

BUZZ-India's Dr.Reddy's hits over 4-month high after U.S. FDA nod

** Shares of Dr. Reddy’s Laboratories Ltd climb as much as 3.4 pct to 2,347.10 rupees - highest since Jan 30

** Stock on track to post gains for a 7th straight session

** More than 950,000 shares traded versus their 30-day moving avg of 794,280

** Co to launch buprenorphine and naloxone sublingual film in the U.S. market after it got the final nod from the U.S. FDA, the Hyderabad-based co said here in a statement

** Buprenorphine and naloxone, a therapeutic equivalent generic version of Suboxone, are used to treat adults with opioid dependence/addiction, the pharma co added

** Stock has fallen 6 pct this year up to Thursday’s close

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below